Safety of the AS04-adjuvanted Human Papillomavirus (HPV)-16/18 Vaccine in Adolescents Aged 12–15 Years: End-Of-Study Results From a Community-Randomized Study Up to 6.5 Years
Human Vaccines and Immunotherapeutics - United States
doi 10.1080/21645515.2019.1692557
Full Text
Open PDFAbstract
Available in full text
Date
December 12, 2019
Authors
Publisher
Informa UK Limited